Holen Sie sich die Stockscreener-App
74.50
0.00%
0.00
Handel nachbörslich:
74.50
Schlusskurs vom Vortag:
$74.50
Offen:
$74.5
24-Stunden-Volumen:
1.67M
Relative Volume:
0.51
Marktkapitalisierung:
$16.62B
Einnahmen:
$4.04B
Nettoeinkommen (Verlust:
$557.10M
KGV:
30.91
EPS:
2.4102
Netto-Cashflow:
$916.70M
1W Leistung:
-0.60%
1M Leistung:
-0.40%
6M Leistung:
+14.42%
1J Leistung:
+2.45%
1-Tages-Spanne:
$74.41
$74.56
1-Wochen-Bereich:
$74.19
$75.03
52-Wochen-Spanne:
$51.90
$75.34
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.50 | 16.62B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
577.81 | 204.60B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
196.33 | 55.88B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.38 | 39.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.76 | 35.68B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.13 | 34.85B | 27.43B | 1.27B | 1.01B | 1.5829 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-21 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Hochstufung | Argus | Hold → Buy |
| 2025-08-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth - Yahoo Finance
Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q3 - TradingView — Track All Markets
Hologic stock (HOLX) after-hours on Dec. 24, 2025: CVR milestone risk, Blackstone–TPG deal spread, and what to watch before the next market open - ts2.tech
Hologic says 2026 CVR is more challenging with stopped shipment of product (HOLX:NASDAQ) - Seeking Alpha
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Diamond Hill Investment Group, Inc. (Nasdaq – DHIL), Synchronoss Technologies (Nasdaq – SNCR), Forge Global Holdings, Inc. (NYSE – FRGE), Hologic, Inc. (Nasdaq – HOLX) - GlobeNewswire Inc.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - Yahoo Finance
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now? - Yahoo Finance
Is Hologic Inc. stock affected by interest rate hikesWeekly Trade Summary & Long-Term Safe Investment Ideas - Улправда
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Why retail investors favor Hologic Inc. stockJuly 2025 Levels & Real-Time Market Sentiment Alerts - Улправда
How sustainable is Hologic Inc. stock dividend payoutEarnings Trend Report & Weekly High Potential Alerts - Улправда
Will Hologic Inc. (HO1) stock sustain uptrend momentumQuarterly Growth Report & Verified Short-Term Plans - Улправда
Is Hologic Inc. stock positioned for digital transformation2025 Fundamental Recap & Low Drawdown Momentum Ideas - Улправда
Can Hologic Inc. stock maintain operating margins2025 Market WrapUp & AI Optimized Trading Strategy Guides - Улправда
Meeting tomorrow's diagnostic demands in today's lab - SelectScience
Why Hologic Inc. stock is recommended by analystsJuly 2025 Closing Moves & Consistent Return Investment Signals - DonanımHaber
Why Hologic Inc. stock is seen as undervaluedMarket Trend Review & Consistent Profit Alerts - DonanımHaber
Will Hologic Inc. stock reach Wall Street targetsEarnings Risk Report & Weekly High Conviction Trade Ideas - DonanımHaber
Can Hologic Inc. stock deliver surprise earnings beat2025 Volume Leaders & Real-Time Volume Surge Alerts - Улправда
Digital Breast Tomosynthesis Equipment Market Set to Boom | - openPR.com
Is Hologic Inc. stock gaining market shareJuly 2025 Big Picture & AI Powered Market Trend Analysis - ulpravda.ru
Market Outlook: Will Hologic Inc. (HO1) stock sustain uptrend momentumMarket Growth Summary & Free Accurate Trade Setup Notifications - moha.gov.vn
Hologic data highlights AI’s role in improving mammography accuracy - DOTmed
Portfolio Shifts: Can Hologic Inc. stock maintain operating marginsTrade Entry Report & Fast Exit and Entry Trade Guides - Улправда
Hologic (HOLX) shareholders have earned a 4.8% return over the last year - Yahoo Finance
Responsive Playbooks and the HOLX Inflection - news.stocktradersdaily.com
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers - sharewise.com
Hologic (HOLX) insider reports 90 shares withheld for tax obligations - Stock Titan
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases - Yahoo Finance
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Bacterial Drug Sensitivity Testing Market Future Outlook - openPR.com
Uterine Fibroid Treatment Market Forecast to 2032 Reveals Key - openPR.com
Virtual Biopsy Market Emerging Player Outperforming | GE Healthcare, Hologic, Hitachi - openPR.com
Hologic’s AI mammography tech flags previously missed breast cancers - Investing.com India
Study: AI-Powered Mammography Technology Helps Flag Breast Cancer Cases Initially Interpreted as Negative - Imaging Technology News
Hologic’s AI mammography tech flags previously missed breast cancers By Investing.com - Investing.com Nigeria
Hologic Says AI Mammography Flagged 32% of Missed Cancers in General Study - marketscreener.com
Hologic's AI-Powered Mammography Technology Flagged a Third of B - GuruFocus
Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening ExamsHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic stock hits 52-week high at $75.14 By Investing.com - Investing.com Canada
Hologic stock hits 52-week high at $75.14 - Investing.com
Hologic's BCI test shows growing impact in endocrine therapy decisions - MSN
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
What Is Driving Hologic's Strength in the US Diagnostics Market? - The Globe and Mail
Hologic ticks higher amid report on financing for potential takeover - MSN
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Is Hologic Stock Outperforming the Nasdaq? - Barchart.com
Halper Sadeh LLC Encourages DHIL, SNCR, FRGE, HOLX Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Edge-GPU Breast Tomosynthesis Box Market Intelligence 2025-2029 Featuring Hologic, GE Healthcare Technologies, Fujifilm, Canon Medical Systems, Philips and MoreResearchAndMarkets.com - The AI Journal
Marshall Wace LLP Purchases Shares of 317,277 Hologic, Inc. $HOLX - MarketBeat
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):